Search Results

Rigel Pharmaceuticals, Inc. MarketLine COMPANY PROFILE.

• Source: Rigel Pharmaceuticals, Inc. MarketLine Company Profile; 2/26/2024, p1-25, 25p

Record details

Biotech News Round-up.

Subjects: DRUG development; STOCK prices; BUSINESS partnershipsSEMAFORE Pharmaceuticals Inc.; BIOMIRA Inc.; MERCK KGaA

• Source: PharmaWatch: Monthly Review; Jan2005, Vol. 4 Issue 1, p36-38, 3p

Record details

MarketLine Company Profile: Rigel Pharmaceuticals, Inc.

• Source: Rigel Pharmaceuticals, Inc. MarketLine Company Profile; 12/23/2022, p1-31, 31p

Record details

MarketLine Company Profile: Rigel Pharmaceuticals, Inc.

• Source: Rigel Pharmaceuticals, Inc. MarketLine Company Profile; 12/29/2021, p1-29, 29p

Record details

MarketLine Company Profile: Rigel Pharmaceuticals, Inc.

• Source: Rigel Pharmaceuticals, Inc. MarketLine Company Profile; 1/16/2020, p1-26, 26p

Record details

MarketLine Company Profile: Rigel Pharmaceuticals, Inc.

• Source: Rigel Pharmaceuticals, Inc. MarketLine Company Profile; 3/27/2019, p1-26, 26p

Record details

MarketLine Company Profile: Rigel Pharmaceuticals, Inc.

• Source: Rigel Pharmaceuticals, Inc. MarketLine Company Profile; 11/4/2016, p1-25, 26p

Record details

Biotechnology News Round-up.

Subjects: BIOTECHNOLOGY; CANCER treatment; UBIQUITINUNITED StatesSEMAFORE Pharmaceuticals Inc.; BIOMIRA Inc.; MERCK & Co. Inc.

• Source: PharmaWatch: Biotechnology; January 2005, Vol. 4 Issue 1, p2-3, 2p

Record details

MarketLine Company Profile: Rigel Pharmaceuticals, Inc.

• Source: Rigel Pharmaceuticals, Inc. MarketLine Company Profile; 7/29/2015, p1-24, 24p

Record details

MarketLine Company Profile: Rigel Pharmaceuticals, Inc.

• Source: Rigel Pharmaceuticals, Inc. MarketLine Company Profile; 10/21/2014, p1-23, 24p

Record details